tiprankstipranks
Trending News
More News >
Capricor Therapeutics (CAPR)
NASDAQ:CAPR
US Market

Capricor Therapeutics (CAPR) Income Statement

Compare
1,234 Followers

Capricor Therapeutics Income Statement

Last quarter (Q3 2025), Capricor Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Capricor Therapeutics's net income was $-24.57M. See Capricor Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 22.27M$ 25.18M$ 2.55M$ 244.90K$ 310.25K
Gross Profit
$ -27.70M$ -11.27M$ -19.27M$ 244.90K$ 310.25K
Operating Expenses
$ 14.87M$ 12.81M$ 10.43M$ 21.18M$ 14.00M
Depreciation and Amortization
$ 1.43M$ 1.07M$ 533.13K$ 245.70K$ 143.89K
EBITDA
$ -41.14M$ -23.01M$ -29.16M$ -20.69M$ -13.55M
Operating Income
$ -42.56M$ -24.08M$ -29.70M$ -20.94M$ -13.69M
Other Income/Expenses
$ 2.10M$ 1.79M$ 677.85K$ 915.92K$ 32.94K
Pretax Income
$ -40.47M$ -22.29M$ -29.02M$ -20.02M$ -13.66M
Net Income
$ -40.47M$ -22.29M$ -29.02M$ -20.02M$ -13.66M
Per Share Metrics
Basic EPS
$ -1.15$ -0.83$ -1.18$ -0.87$ -0.88
Diluted EPS
$ -1.15$ -0.83$ -1.18$ -0.87$ -0.88
Weighted Average Shares Outstanding
35.22M 26.78M 24.55M 23.09M 15.57M
Weighted Average Shares Outstanding (Diluted)
35.22M 26.78M 24.55M 23.09M 15.57M
Currency in USD

Capricor Therapeutics Earnings and Revenue History